Visura Technologies has developed TEECAD, the first FDA-cleared disposable camera that attaches to transesophageal echocardiogram (TEE) probes, providing real-time visualization during intubation. This technology enhances the accuracy of probe placement and reduces oropharyngeal injuries by 50%, significantly improving patient safety and procedural efficiency.
Funding
$16.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
During transesophageal echocardiogram (TEE) procedures, blind intubation can lead to inaccurate probe placement and oropharyngeal injuries, potentially compromising patient safety and procedural efficiency. Traditional methods lack real-time visualization, increasing the risk of complications.
Solution
Visura Technologies offers TEECAD, a disposable camera that attaches to TEE probes, providing physicians with real-time visualization during intubation. This FDA-cleared technology enables precise probe placement, reducing the need for blind navigation. By offering a clear view of the esophagus, TEECAD aims to minimize oropharyngeal injuries and improve first-pass intubation success rates. The device's atraumatic design and seamless integration with TEE probes contribute to a safer and more efficient TEE procedure.
Target Audience
The primary users are cardiologists and other medical professionals performing transesophageal echocardiograms in hospitals, outpatient settings, and structural heart cases.
Features
- Disposable camera seamlessly attaches to TEE probes for real-time visualization.
- Provides clear images of the esophagus during intubation.
- Atraumatic, soft silicone design minimizes patient discomfort.
- Facilitates precise and effective probe placement.
- Demonstrated to reduce oropharyngeal injuries by 50% in clinical data.
- Shown to improve first-pass intubation success rates compared to blind intubation.